Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease
NCT04855955 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2024-02-07
Summary
This is a single patient emergency expanded access clinical study to assess the safety of administering autologous AdMSCs to an incurable Alzheimer disease patient. The study subject will be evaluated for disease-associated severity according to symptoms, cognitive function, memory, and quality of life.
Conditions
- Alzheimer Disease
Interventions
- DRUG
-
Adipose-Derived Mesenchymal Stem Cells
Sponsors & Collaborators
-
Celltex Therapeutics Corporation
lead INDUSTRY
Principal Investigators
-
Richard L Neel, M.D. · Little Alsace Urgent Care Center
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease
NCT02054208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease
NCT04388982 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease
NCT01297218 ·Status: COMPLETED ·Phase: PHASE1
-
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
NCT02600130 ·Status: COMPLETED ·Phase: PHASE1
-
Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®
NCT04954534 ·Status: UNKNOWN ·Phase: NA
-
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
NCT01807026 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia
NCT02185053 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease
NCT01547689 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety Study of CTS21166 to Treat Alzheimer Disease
NCT00621010 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease
NCT03117738 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
NCT00455000 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT03802162 ·Status: COMPLETED ·Phase: PHASE1
-
ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
NCT04488419 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
NCT06745583 ·Status: RECRUITING ·Phase: PHASE2
-
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
NCT02537938 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of MT-4666
NCT01764243 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
NCT03172117 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease
NCT01864655 ·Status: COMPLETED ·Phase: PHASE1
-
A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease
NCT05792163 ·Status: COMPLETED ·Phase: PHASE1
-
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
NCT03806478 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety Study of MT-4666 in Subjects With Alzheimer's Disease
NCT02327182 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
NCT05040217 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
NCT04971733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
NCT01482013 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
NCT05104463 ·Status: COMPLETED ·Phase: PHASE2